No Data
No Data
MedicalSystem Biotechnology Gets Nod to Register Two Devices in Zhejiang, China
Chinese in vitro diagnostic product manufacturer MedicalSystem Biotechnology (SHE:300439) obtained medical device registration certificates from the drug regulator of China's Zhejiang Province for two
BRICS New Development Bank Extends $50 Million Loan for Sustainable Infrastructure in Zhejiang
Multilateral lender BRICS New Development Bank issued a $50 million loan equivalent in renminbi to the Bank of Huzhou to fund sustainable infrastructure in Zhejiang province, Xinhua News Agency report
Zhejiang China Commodities City's Chairman Resigns
Zhao Wenge, the chairman of Zhejiang China Commodities City Group (SHA:600415), resigned due to organizational work arrangements, according to the company's disclosure on the Shanghai Stock Exchange.
Zhejiang Jiaotong Technology (002061.SZ) 2023 equity distribution: 1.25 yuan for every 10 shares, share registration on June 4
Zhitong Finance App News, Zhejiang Jiaotong (002061.SZ) announced that the company's 2023 equity distribution plan is to distribute RMB 1.25 in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital. The share registration date for this equity distribution is June 4, 2024, and the ex-dividend date is June 5, 2024.
Zhejiang East Asia Pharmaceutical Gets WHO Approval for Levofloxacin
Zhejiang East Asia Pharmaceutical (SHA:605177) became a recommended supplier of the World Health Organization after receiving a certificate for its raw drug ingredient levofloxacin, according to a Tue
China Grants Clinical Trial Approval for Zhejiang Medicine's Antibacterial Injection
China's medical products administrator granted clinical trial approval to Zhejiang Medicine's (SHA:600216) LYSC98 injectable antibacterial drug indicated for common clinical gram-positive bacteria, ac
No Data